172 results
8-K
EX-10.1
CYCC
Cyclacel Pharmaceuticals Inc
2 May 24
Cyclacel Pharmaceuticals ANNOUNCES $8.0 MILLION PRIVATE PLACEMENT
5:00pm
relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each … case as could not have or reasonably be expected to result in a Material Adverse Effect.
(m) Environmental Laws. The Company and its Subsidiaries (i
424B3
CYCC
Cyclacel Pharmaceuticals Inc
14 Feb 24
Prospectus supplement
4:06pm
that results from our use or the use by third parties of these materials. Compliance with environmental laws and regulations may be expensive, and current … or future environmental regulations may impair our research, development and production efforts.
Our business and operations would suffer
8-K
EX-10.2
vxa0i
26 Dec 23
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
9:29am
8-K
EX-1.1
yiffc6i
15 Mar 21
Cyclacel Pharmaceuticals Prices $12.65 Million
5:21pm
D
7jkfghlcss4d67
4 Jan 21
$7M in equity / options / securities to be acquired, sold $7M, 1 investor
10:54am
8-K
EX-10.1
taoeydin
22 Dec 20
Cyclacel Pharmaceuticals ANNOUNCES At-the-market $7 MILLION strategic INVESTMENT BY FUNDAMENTAL INVESTOR ACORN BIOVENTURES
4:05pm
8-K
EX-1.2
vbdcfgw8sb d5pjuf
24 Apr 20
Cyclacel Announces PRICING OF $20 MILLION PUBLIC OFFERING
4:38pm
8-K
EX-1.1
rgskjhupcivgf2y
4 Oct 18
Entry into a Material Definitive Agreement
4:30pm